Whole-ovary decellularization generates an effective 3D bioscaffold for ovarian bioengineering.
3D bioscaffold
Decellularization
Extracellular matrix
Porcine
Whole ovary
Journal
Journal of assisted reproduction and genetics
ISSN: 1573-7330
Titre abrégé: J Assist Reprod Genet
Pays: Netherlands
ID NLM: 9206495
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
16
12
2019
accepted:
14
04
2020
pubmed:
4
5
2020
medline:
4
2
2021
entrez:
4
5
2020
Statut:
ppublish
Résumé
To develop a new protocol for whole-ovary decellularization for the production of a 3D bioscaffold suitable for in vitro/ex vivo studies and for the reconstruction of a bioengineered ovary. Porcine ovaries were subjected to the decellularization process (DECELL; n = 20) that involved a freeze-thaw cycle, followed by sequential incubations in 0.5% SDS for 3 h, 1% Triton X-100 for 9 h, and 2% deoxycholate for 12 h. Untreated ovaries were used as a control (CTR; n = 6). Both groups were analyzed to evaluate cell and DNA removal as well as ECM preservation. DECELL bioscaffolds were assessed for cytotoxicity and cell homing ability. DECELL ovaries maintained shape and homogeneity without any deformation, while their color turned from red to white. Histological staining and DNA quantification confirmed a decrease of 98.11% in DNA content, compared with the native tissue (CTR). Histochemical assessments demonstrated the preservation of intact ECM microarchitecture after the decellularization process. This was also confirmed by quantitative analysis of collagen, elastin, and GAG contents. DECELL bioscaffold showed no cytotoxic effects in co-culture and, when re-seeded with homologous fibroblasts, encouraged a rapid cell adhesion and migration, with repopulating cells increasing in number and aggregating in cluster-like structures, consistent with its ability to sustain cell adherence, proliferation, and differentiation. The protocol described allows for the generation of a 3D bioscaffold that may constitute a suitable model for ex vivo culture of ovarian cells and follicles, as well as a promising tool for the reconstruction of a bioengineered ovary.
Identifiants
pubmed: 32361917
doi: 10.1007/s10815-020-01784-9
pii: 10.1007/s10815-020-01784-9
pmc: PMC7311562
doi:
Substances chimiques
Octoxynol
9002-93-1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1329-1339Subventions
Organisme : Carraresi Foundation
ID : ND
Organisme : PSR2017
ID : ND
Commentaires et corrections
Type : ErratumIn
Références
Biol Reprod. 2000 Aug;63(2):457-61
pubmed: 10906050
Curr Opin Endocrinol Diabetes Obes. 2015 Dec;22(6):483-9
pubmed: 26512773
Hum Reprod Update. 2015 Nov-Dec;21(6):787-808
pubmed: 26243799
Int J Med Sci. 2015 Apr 06;12(4):336-40
pubmed: 25897295
Tissue Eng Part C Methods. 2017 Feb;23(2):61-71
pubmed: 27981878
J Ovarian Res. 2019 Jun 22;12(1):58
pubmed: 31228949
Biomaterials. 2015 May;50:20-9
pubmed: 25736492
Int J Mol Sci. 2018 Dec 18;19(12):
pubmed: 30567407
Nat Commun. 2017 May 16;8:15261
pubmed: 28509899
Theriogenology. 2020 Jul 1;150:8-14
pubmed: 31973967
Mater Sci Eng C Mater Biol Appl. 2019 Sep;102:670-682
pubmed: 31147040
Fertil Steril. 2013 Oct;100(4):1122-31
pubmed: 23830108
Reprod Sci. 2007 May;14(4):358-66
pubmed: 17644808
Hum Reprod. 2019 Aug 1;34(8):1523-1535
pubmed: 31286144
Fertil Steril. 2014 Jul;102(1):19-26
pubmed: 24890275
Semin Reprod Med. 2001 Sep;19(3):221-30
pubmed: 11679903
Eur J Obstet Gynecol Reprod Biol. 2006 Feb 1;124(2):250-3
pubmed: 16144734
Biomacromolecules. 2017 Apr 10;18(4):1229-1237
pubmed: 28277649
Nat Med. 2010 Jul;16(7):814-20
pubmed: 20543851
Biomaterials. 2010 Mar;31(9):2549-54
pubmed: 20061016
Stem Cell Res Ther. 2013;4 Suppl 1:S13
pubmed: 24565375
Blood. 2010 Oct 21;116(16):2908-14
pubmed: 20595517
Pediatr Hematol Oncol. 2007 Jan-Feb;24(1):29-44
pubmed: 17130112
Semin Immunol. 2017 Feb;29:72-91
pubmed: 28274693
Sex Med Rev. 2018 Jan;6(1):35-44
pubmed: 29066225
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Lancet. 1986 Apr 19;1(8486):884-6
pubmed: 2870356
Mol Reprod Dev. 2001 Oct;60(2):189-95
pubmed: 11553917
Theriogenology. 2006 Jan 7;65(1):236-44
pubmed: 16289262
Stem Cell Res Ther. 2018 Sep 26;9(1):252
pubmed: 30257706
Ann Thorac Surg. 2013 Sep;96(3):1046-55; discussion 1055-6
pubmed: 23870827
Nat Commun. 2014 Apr 15;5:3562
pubmed: 24736316
Adv Drug Deliv Rev. 2015 Mar;82-83:145-52
pubmed: 25453265
Biomaterials. 2014 Mar;35(10):3252-62
pubmed: 24439414
Hum Reprod. 2015 Mar;30(3):608-15
pubmed: 25567618
Nat Rev Endocrinol. 2013 Dec;9(12):735-49
pubmed: 24166000
Hum Reprod. 2014 Jan;29(1):114-24
pubmed: 24135077
Anim Reprod. 2020 May 22;16(1):45-51
pubmed: 33299478
Sci Rep. 2019 Dec 27;9(1):20001
pubmed: 31882863
Biomed Res Int. 2017;2017:9831534
pubmed: 28540307
Fertil Steril. 2013 May;99(6):1503-13
pubmed: 23635349
Semin Reprod Med. 2015 Mar;33(2):128-44
pubmed: 25734350
Biomaterials. 2014 Jan;35(3):970-82
pubmed: 24183165
Cancer. 2006 Oct 1;107(7 Suppl):1690-4
pubmed: 16902945
Biores Open Access. 2017 Jun 01;6(1):74-84
pubmed: 28736690
Hum Reprod. 2008 May;23(5):1007-13
pubmed: 18344563
J Biomed Mater Res A. 2017 Jul;105(7):1949-1959
pubmed: 28294563
Best Pract Res Clin Obstet Gynaecol. 2019 Feb;55:23-36
pubmed: 30249473
Blood. 2012 Nov 22;120(22):4311-6
pubmed: 22709693
Theriogenology. 2020 Jul 1;150:2-7
pubmed: 31973966
Biomaterials. 2014 Aug;35(25):6822-8
pubmed: 24855960
Maturitas. 2014 Jan;77(1):12-9
pubmed: 24210634
Biomaterials. 2014 Aug;35(24):6344-50
pubmed: 24818885
Reprod Biomed Online. 2007 Jun;14(6):758-64
pubmed: 17579993